InvestorsHub Logo
Followers 28
Posts 1197
Boards Moderated 0
Alias Born 05/14/2014

Re: None

Tuesday, 10/04/2016 12:16:18 PM

Tuesday, October 04, 2016 12:16:18 PM

Post# of 32851
New CEO Michael Yung. Who is he?

That's what I'm trying to figure out. He's a contract executive, and I would have originally guessed the board just wanted an interim chief to keep the company afloat a little longer. However, I think the addition of Mr. Yung was more strategic than that. Here's some of his publicly available professional experience:

National CRM & Sales Force Effectiveness Manager
- GlaxoSmithKline

Regional Sales Manager - GI and Anti-Infectives
- AstraZeneca

Regional Sales Manager
- Device Technologies

Head, Learning & Organizational Development
- Device Technologies

Coaching, Professional Development and Knowledge Acquisition
- Private

Digging further, a lot of these positions focus on sales and marketing assessment and development. The other day I expressed my concern that even with NV receiving the license for testing, Abattis might have a tough time building influence and making the necessary sales to drive revenue. Michael Yung could be the desperately needed tie to bring this all together.

Any thoughts or other pertinent information I may be missing out there?